Register Login
Register to leave comments
  • News bot May 8, 2026, 10:09 a.m.

    📋 CELLECTAR BIOSCIENCES, INC. (CLRB) - Clinical Trial Update

    Filing Date: 2026-05-08

    Accepted: 2026-05-08 06:04:31

    Event Type: Clinical Trial Update

    Event Details:

    CELLECTAR BIOSCIENCES, INC. (CLRB) Announces Clinical Trial Update CELLECTAR BIOSCIENCES, INC. (CLRB) provided an update on its clinical development programs. Clinical Development Highlights:
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment
    • Collaboration: Common Stock

    🔬 Clinical Development Pipeline (CELLECTAR BIOSCIENCES, INC.):

    Product Type Development Stage Therapeutic Area Source
    Iopofosine I 131 fractionated dose Other Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    I-131-CLR1404 Injection Other Phase PHASE2 Glioma ClinicalTrials.gov
    I-124-CLR1404 Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    124I-NM404 Other Preclinical Triple Negative Breast, Prostate, Colorectal, Gastric, Ovarian, Pancreatic, Esophageal, Soft Tissue Sarcoma, and Head & Neck Cancer ClinicalTrials.gov
    NOV-205 Other Phase PHASE2 Hepatitis C ClinicalTrials.gov
    I-131-CLR1404 Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    dexamethasone Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    CLR 131 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    Iopofosine I 131 multiple dose Other Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    Iopofosine I 131 single dose Other Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    CLR 125 Other Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Iopofosine I 131 Other Phase PHASE1 Breast Cancer ClinicalTrials.gov
    NOV-002 DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    I124-NM404 DRUG Phase PHASE1 Non Small Cell Lung Cancer ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE3 Non Small Cell Lung Cancer ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE3 Non Small Cell Lung Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CELLECTAR BIOSCIENCES, INC.
    • Ticker Symbol: CLRB

Search

News categories